New cancer drug trial hopes to shrink tumors
NCT ID NCT05103683
First seen Feb 18, 2026 · Last updated Jun 17, 2026 · Updated 26 times
Summary
This early-stage study tests a new drug, TORL-1-23, in 90 people with advanced solid tumors like ovarian, endometrial, or lung cancer. The main goals are to find a safe dose and check for side effects. Researchers will also see if the drug can shrink tumors or slow cancer growth.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asan Medical Center
RECRUITINGSeoul, 05505, South Korea
Contact
Contact
-
Cleveland Clinic
RECRUITINGCleveland, Ohio, 44195, United States
Contact
-
Mayo Clinic in Rochester
RECRUITINGRochester, Minnesota, 55905, United States
Contact Phone: •••-•••-••••
Contact
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
Contact
-
Providence Medical Foundation
RECRUITINGFullerton, California, 92835, United States
Contact
-
Samsung Medical Center
RECRUITINGSeoul, 06351, South Korea
Contact
Contact
-
Sarah Cannon Research Institute Texas Oncology
RECRUITINGTyler, Texas, 75702, United States
Contact
Contact
-
Seoul National University Hospital
RECRUITINGSeoul, 03080, South Korea
Contact
Contact
-
Severance Hospital
RECRUITINGSeoul, 03723, South Korea
Contact
Contact
-
St. Vincent's Hospital, The Catholic University of Korea
RECRUITINGSuwon, Gyeonggi-do, 16247, South Korea
Contact
Contact
-
UCLA - JCCC Clinical Research Unit
RECRUITINGLos Angeles, California, 90095, United States
Contact
Contact Phone: •••-•••-••••
-
University of Kentucky Medical Center
RECRUITINGLexington, Kentucky, 40536, United States
Contact
-
University of Minnesota
RECRUITINGMinneapolis, Minnesota, 55455, United States
Contact Phone: •••-•••-••••
Contact
-
Virginia Cancer Specialists
RECRUITINGFairfax, Virginia, 22031, United States
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.